U.S., Sept. 24 -- An application to own the trademark for 'FYRELFI' has been filed on Nov. 27, 2024.
Owner(s):
JW PHARMACEUTICAL CORPORATION; 38, Gwacheon-daero 7-gil,, , REPUBLIC OF KOREA
Goods and/or Services:
For: Chemico-pharmaceutical preparations for the treatment of gout, inflammatory diseases, kidney disorders, metabolic disorders and musculoskeletal disorders.
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-09-23&serialNumber=79415057
Disclaimer: Curated by HT Syndication....